This month, MedMarket Diligence is publishing its biennial report on the global wound care market, “Worldwide Wound Management, Forecast to 2026: Established and Emerging Products, Technologies and Markets in the Americas, Europe, Asia/Pacific and Rest of World.” Details.
Markets for medical technologies work according to the forces in play where products sell. There is no “global market”, per se, but an amalgamation of far-flung markets where, in one country, a new technology is embraced, and in another it’s passe or taboo or too expensive or de rigueur.
Cultural differences regarding medicine can be significant. How the sick are treated socially, how wounds are considered, the value of an innovation — may all be viewed differently through local lenses.
Differences in effective sales and distribution can exist, particularly for new technologies, in technology-importing countries.
Regulatory differences can be HUGE. Besides the timing of FDA PMA or 510(K) versus the CE mark for the same technology, the regulatory entities are not entirely in sync regarding approval for new technologies.
On the global playing field, all active players know that some countries sre better than others at allowing foreign conpetition.
Even well established products, like traditional wound products (gauze, adherent, non-adherent), remain less well established in emerging markets.
below are the shares of each country’s total wound market represented by each technology, for non-adherent dressings, adherent dressings, gauze dressings, NPWT, and antimicrobial wound products.
The net effect on local markets?
— Each country has greater/lesser demand for different technologies
Technology/Treatment Share of Country Total Wound Market
[For example, non-adherent wound dressings represent a little over 6% of the U.S. market, but as much as 16% of the market in China, and under 4% of the aggregate wound market in the rest of Asia/Pacific (Australia, India, etc.).]
Source: MedMarket Diligence, LLC; Report S254.
Other traditional products like adherent dressings and gauze show a pattern of lesser use in the U.S., western European countries, and Japan.
Traditional gauze is a less significant component of the U.S. or Japan, both of which have rapidly adopted and instead use more advanced technologies.
Negative Pressure Wound Therapy, a more involved wound care technology, shows different patterns in demand across countries than other wound products.
The actual level of risk of infection, the perceived risk of infection, and the resulting differences in adoption of antimicrobials give rise to some different adoption than one might expect.
Markets for advanced wound care technologies, such bioengineered skin or growth factors (not shown), illustrates a common dynamic, with the highest country use being the U.S. and whose manufacturers have often pursued the U.S. market for new technology introduction, to be followed by Europe, Asia, South America, etc. as technology migrates to less well developed markets.
Other products in wound with their own country-to-country dynamics include film dressings, foam, hydrogel, hydrocolloid, alginate, collagen, and growth factors.
See Report #S254, publishing March 2018.